FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
capitalbrief41m
Final countdown
Jim Chalmers didn’t quite declare “mission accomplished” on inflation this week. But if the Reserve Bank cuts rates in ...